Thermodynamic stability of wild-type and mutant p53 core domain

被引:364
|
作者
Bullock, AN
Henckel, J
DeDecker, BS
Johnson, CM
Nikolova, PV
Proctor, MR
Lane, DP
Fersht, AR
机构
[1] Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England
[2] Univ Cambridge, Ctr Mrc, Cambridge Ctr Prot Engn, Cambridge CB2 2QH, England
[3] Univ Dundee, Dept Biochem, Canc Res Campaign Labs, Dundee DD1 4HN, Scotland
关键词
tumor suppressor; denaturation; folding; zinc; protein;
D O I
10.1073/pnas.94.26.14338
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Some 50% of human cancers are associated with mutations in the core domain of the tumor suppressor p53, Many mutations are thought just to destabilize the protein, To assess this and the possibility of rescue, we have set up a system to analyze the stability of the core domain and its mutants, The use of differential scanning calorimetry or spectroscopy to measure its melting temperature leads to irreversible denaturation and aggregation and so is useful as only a qualitative guide to stability, There are excellent two-state denaturation curves on the addition of urea that may be analyzed quantitatively, One Zn2+ ion remains tightly bound in the hole-form of p53 throughout the denaturation curve, The stability of wild type is 6.0 kcal (1 kcal = 4.18 kJ)/mol at 25 degrees C and 9.8 kcal/mol at 10 degrees C, The oncogenic mutants R175H, C242S, R248Q, R249S, and R273H are destabilized by 3.0, 2.9, 1.9, 1.9, and 0.4 kcal/mol, respectively, Under certain denaturing conditions, the wildtype domain forms an aggregate that is relatively highly fluorescent at 340 nm on excitation at 280 nm, The destabilized mutants give this fluorescence under milder denaturation conditions.
引用
收藏
页码:14338 / 14342
页数:5
相关论文
共 50 条
  • [41] The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment
    Li, Dan-Dan
    Sun, Ting
    Wu, Xiao-Qi
    Chen, Shu-Peng
    Deng, Rong
    Jiang, Shan
    Feng, Gong-Kan
    Pan, Jing-Xuan
    Zhang, Xiao-Shi
    Zeng, Yi-Xin
    Zhu, Xiao-Feng
    [J]. PLOS ONE, 2012, 7 (09):
  • [42] Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability
    Lu, YiQing
    Cho, Tiffany
    Mukherjee, Saptaparna
    Suarez, Carmen Florencia
    Gonzalez-Foutel, Nicolas S.
    Malik, Ahmad
    Martinez, Sebastien
    Dervovic, Dzana
    Oh, Robin Hyunseo
    Langille, Ellen
    Al-Zahrani, Khalid N.
    Hoeg, Lisa
    Lin, Zhen Yuan
    Tsai, Ricky
    Mbamalu, Geraldine
    Rotter, Varda
    Ashton-Prolla, Patricia
    Moffat, Jason
    Chemes, Lucia Beatriz
    Gingras, Anne-Claude
    Oren, Moshe
    Durocher, Daniel
    Schramek, Daniel
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2024, 20 (06) : 719 - 740
  • [43] Contribution of the p53 pathway in cancers that carry wild-type p53
    Ohki, Rieko
    [J]. CANCER SCIENCE, 2022, 113 : 1232 - 1232
  • [44] Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation
    Kaypee, Stephanie
    Sahadevan, Smitha Asoka
    Patil, Shilpa
    Ghosh, Piya
    Roy, Neeladri Sekhar
    Roy, Siddhartha
    Kundu, Tapas K.
    [J]. ISCIENCE, 2018, 4 : 260 - +
  • [45] THE CORE PROMOTER REGION OF THE P-GLYCOPROTEIN GENE IS SUFFICIENT TO CONFER DIFFERENTIAL RESPONSIVENESS TO WILD-TYPE AND MUTANT P53
    ZASTAWNY, RL
    SALVINO, R
    CHEN, JM
    BENCHIMOL, S
    LING, V
    [J]. ONCOGENE, 1993, 8 (06) : 1529 - 1535
  • [46] Characterization of wild-type and mutant p53 protein by Raman spectroscopy and multivariate methods
    Hernandez-Vidales, Karen
    Guevara, Edgar
    Olivares-Illana, Vanesa
    Gonzalez, Francisco Javier
    [J]. JOURNAL OF RAMAN SPECTROSCOPY, 2019, 50 (10) : 1388 - 1394
  • [47] Wild-type and mutant p53 proteins interact with mitochondrial caspase-3
    Frank, Amanda K.
    Pietsch, E. Christine
    Dumont, Patrick
    Tao, Joy
    Murphy, Maureen E.
    [J]. CANCER BIOLOGY & THERAPY, 2011, 11 (08) : 740 - 745
  • [48] Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53
    Pfister, Neil T.
    Prives, Carol
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (02):
  • [49] SENSITIVITY OF COMPETITIVE HYBRIDIZATION FOR THE DETECTION OF MUTANT P53 ALLELES IN A BACKGROUND OF WILD-TYPE
    CARPENTER, K
    MORGAN, K
    DURRANT, LG
    HARDCASTLE, JD
    KALSHEKER, N
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) : S129 - S129
  • [50] Identification of autoantibody biomarkers to wild-type and mutant p53 in pancreatic and ovarian cancer
    Katchman, Benjamin A.
    Alam, Rizwan
    Wallstrom, Garrick
    LaBaer, Joshua
    Hollingsworth, Michael A.
    Cramer, Daniel W.
    Anderson, Karen S.
    [J]. CANCER RESEARCH, 2014, 74 (19)